These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 13752496)

  • 1. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma.
    SHANBROM E; MILLER S; HAAR H; OPFELL R
    JAMA; 1960 Nov; 174():1702-5. PubMed ID: 13750663
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
    THEOLOGIDES A; KENNEDY BJ
    Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias.
    STUTZMAN L; RAZIS DV; SOKAL JE; AMBRUS JL; ROSS CA
    Cancer Chemother Rep; 1962 May; 18():31-5. PubMed ID: 13918060
    [No Abstract]   [Full Text] [Related]  

  • 7. [On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases].
    PETROV KIa
    Sov Med; 1961 Nov; 25():13-7. PubMed ID: 14485925
    [No Abstract]   [Full Text] [Related]  

  • 8. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD].
    BALLERINI G; CASTOLDI G; RICCI N; TENZE L
    Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587
    [No Abstract]   [Full Text] [Related]  

  • 9. Uracil mustard revisited.
    Kennedy BJ; Torkelson JL; Torlakovic E
    Cancer; 1999 May; 85(10):2265-72. PubMed ID: 10326707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFECT OF TESTOSTERONE ENANTHATE AND ALKYLATING AGENTS ON MULTIPLE MYELOMA.
    BRODSKY I; DENNIS LH; DECASTRO NA; BRADY L; KAHN SB
    JAMA; 1965 Sep; 193():874-8. PubMed ID: 14341128
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of epoxypiperazine, a new alkylating agent, in the treatment of lymphomas and other neoplasms.
    MILLER DG; DIAMOND HD; CRAVER LF
    Cancer Res; 1959 Dec; 19():1204-9. PubMed ID: 14422486
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in chemotherapy illustrated by the cytostatic 5-fluoruracil and the leukemias].
    OBRECHT P
    Strahlentherapie; 1961; Suppl 48():65-73. PubMed ID: 14481028
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors.
    WALL RL; CONRAD FG
    Arch Intern Med; 1961 Sep; 108():456-82. PubMed ID: 13782776
    [No Abstract]   [Full Text] [Related]  

  • 14. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS.
    PETERING HG; VANGIESSEN GJ
    J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966
    [No Abstract]   [Full Text] [Related]  

  • 15. The antitumor activity of 5-bis-2'-chlorethyl)-aminouracil (uracil mustard).
    LANE M; KELLY MG
    Cancer Res; 1960 May; 20():511-7. PubMed ID: 14413839
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine.
    HILL JM; LOEB E
    Cancer Chemother Rep; 1961 Dec; 15():41-61. PubMed ID: 13907352
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy in leukemia and malignant reticulosis].
    ARIENS EJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1919-22. PubMed ID: 13794222
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of the malignant lymphomas and leukemias.
    GAMBLE JF
    Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
    [No Abstract]   [Full Text] [Related]  

  • 20. 2-Fluoroethylamines. 3. Some alkylating agents derived from uracil.
    Martinez AP; Lee WW; Goodman L
    J Med Chem; 1968 Mar; 11(2):384-7. PubMed ID: 5663637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.